Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 3 | 2017 | 32 | 0.160 |
Why?
|
| Cytokines | 3 | 1997 | 18 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 100 | 0.150 |
Why?
|
| Receptors, CCR7 | 1 | 2017 | 4 | 0.140 |
Why?
|
| Synovial Membrane | 1 | 2017 | 6 | 0.140 |
Why?
|
| Arthritis | 4 | 1999 | 4 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 1999 | 21 | 0.130 |
Why?
|
| Osteoarthritis | 1 | 2017 | 45 | 0.130 |
Why?
|
| Proteoglycans | 2 | 1994 | 11 | 0.130 |
Why?
|
| Intestines | 1 | 1994 | 2 | 0.110 |
Why?
|
| Joint Diseases | 1 | 1994 | 2 | 0.110 |
Why?
|
| Spinal Diseases | 1 | 1994 | 2 | 0.110 |
Why?
|
| Collagen | 3 | 1999 | 22 | 0.080 |
Why?
|
| Humans | 8 | 2017 | 1908 | 0.080 |
Why?
|
| Mice | 5 | 2017 | 215 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1999 | 9 | 0.060 |
Why?
|
| Animals | 5 | 2017 | 751 | 0.060 |
Why?
|
| Male | 5 | 2017 | 1057 | 0.050 |
Why?
|
| Spondylitis, Ankylosing | 2 | 1994 | 2 | 0.050 |
Why?
|
| Interleukin-12 | 2 | 1999 | 4 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 418 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 1999 | 4 | 0.040 |
Why?
|
| Middle Aged | 2 | 2017 | 494 | 0.040 |
Why?
|
| Pyrrolidinones | 1 | 1997 | 1 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1997 | 1 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1997 | 4 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 2017 | 4 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 25 | 0.030 |
Why?
|
| Sepharose | 2 | 1994 | 2 | 0.030 |
Why?
|
| Rheumatoid Nodule | 2 | 1993 | 2 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 554 | 0.030 |
Why?
|
| Aspergillosis | 1 | 1995 | 1 | 0.030 |
Why?
|
| Thoracic Diseases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Mice, Inbred DBA | 3 | 1999 | 3 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1994 | 4 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 10 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 1994 | 8 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1994 | 1 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 36 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1994 | 9 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 1994 | 88 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1993 | 1 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 1 | 0.030 |
Why?
|
| HIV Infections | 1 | 1994 | 77 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 1992 | 2 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1992 | 2 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1992 | 6 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 1990 | 1 | 0.020 |
Why?
|
| Immunotherapy | 2 | 1999 | 5 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1999 | 14 | 0.020 |
Why?
|
| Down-Regulation | 2 | 1999 | 19 | 0.020 |
Why?
|
| CD4 Antigens | 2 | 1997 | 4 | 0.020 |
Why?
|
| Gene Expression | 2 | 1997 | 27 | 0.010 |
Why?
|
| Clone Cells | 2 | 1993 | 4 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 4 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 4 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1999 | 5 | 0.010 |
Why?
|
| Joints | 1 | 1999 | 9 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 67 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 10 | 0.010 |
Why?
|
| Rolipram | 1 | 1997 | 1 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 14 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 6 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 8 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 9 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1995 | 1 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1995 | 7 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1995 | 52 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1993 | 2 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1993 | 3 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1993 | 3 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 7 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1993 | 13 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 18 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1992 | 3 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 1992 | 3 | 0.010 |
Why?
|
| Ileum | 1 | 1992 | 3 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1992 | 9 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1990 | 1 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1990 | 1 | 0.010 |
Why?
|
| Gels | 1 | 1990 | 2 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 8 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1990 | 3 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1990 | 31 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1990 | 60 | 0.010 |
Why?
|
| Female | 1 | 1993 | 985 | 0.010 |
Why?
|